1. Introduction
===============

In recent years, marine sponges have emerged as one of the most prolific sources for discovery of novel secondary metabolites \[[@B1-marinedrugs-10-01536],[@B2-marinedrugs-10-01536],[@B3-marinedrugs-10-01536]\]. Some of these have been found to possess several kinds of biological activities, such as cytotoxic \[[@B4-marinedrugs-10-01536],[@B5-marinedrugs-10-01536]\], antimicrobial \[[@B6-marinedrugs-10-01536]\], and antiviral properties \[[@B7-marinedrugs-10-01536]\]. 4-Methylenesterols were first reported in 1981 as being obtained from two marine sponges, *Theonella conica* and *Theonella swinhoei*, from the Red Sea \[[@B8-marinedrugs-10-01536]\]. Marine sponges of the genus *Theonella* are now known to be a rich source of novel 4-methylene sterols \[[@B8-marinedrugs-10-01536],[@B9-marinedrugs-10-01536],[@B10-marinedrugs-10-01536],[@B11-marinedrugs-10-01536],[@B12-marinedrugs-10-01536],[@B13-marinedrugs-10-01536],[@B14-marinedrugs-10-01536],[@B15-marinedrugs-10-01536],[@B16-marinedrugs-10-01536],[@B17-marinedrugs-10-01536],[@B18-marinedrugs-10-01536],[@B19-marinedrugs-10-01536],[@B20-marinedrugs-10-01536],[@B21-marinedrugs-10-01536]\]. Some of these sterols display a variety of biological activities, and pharmacological evaluation has shown them to be modulators of two well-known nuclear receptors, FXR and PXR \[[@B16-marinedrugs-10-01536],[@B17-marinedrugs-10-01536],[@B18-marinedrugs-10-01536],[@B19-marinedrugs-10-01536],[@B20-marinedrugs-10-01536],[@B21-marinedrugs-10-01536]\], and cytotoxic activity \[[@B9-marinedrugs-10-01536]\]. Furthermore, a recently published report indicates that theonellasterol (**4**) is a highly selective FXR antagonist that protects against cholestatic liver injury \[[@B21-marinedrugs-10-01536]\]. Research into the pharmacological properties of this class of natural products is of particular interest. Our investigation of the chemical constituents of the sponge *Theonella swinhoei* ([Figure 1](#marinedrugs-10-01536-f001){ref-type="fig"}) yielded three new 4-methylene sterols, theonellasterol K (**1**), acetyltheonellasterol (**2**) and acetyldehydroconicasterol (**3**), along with two known sterols, theonellasterol (**4**) \[[@B8-marinedrugs-10-01536]\] and theonellasterone (**5**) \[[@B10-marinedrugs-10-01536]\] ([Chart 1](#marinedrugs-10-01536-f004){ref-type="fig"}). The structures of **1--5** were established by detailed spectroscopic analysis, including extensive examination of 2D NMR (^1^H-^1^H COSY, HMQC and HMBC) correlations. The cytotoxicity of metabolites **1--5** against human colorectal carcinoma (DLD-1), human hormone-dependent breast cancer (T-47D), human colon adenocarcinoma (HCT-116), human breast adenocarcinoma (MCF-7 and MDA-MB-231), human chronic myelogenous leukemia (K562) and human T lymphoblast, acute lymphoblastic leukemia (Molt 4) was studied in order to discover bioactive compounds.

![Sponge *Theonella swinhoei.*](marinedrugs-10-01536-g001){#marinedrugs-10-01536-f001}

![Structures of metabolites **1--5**.](marinedrugs-10-01536-g004){#marinedrugs-10-01536-f004}

2. Results and Discussion
=========================

The EtOAc extract of the freeze-dried specimen was fractionated by silica gel column chromatography and the eluted fractions were further separated utilizing normal phase HPLC to yield metabolites **1--5**. The new compounds were given the trivial names theonellasterol K (**1**), acetyltheonellasterol (**2**) and acetyldehydroconicasterol (**3**). The known compounds were identified as theonellasterol (**4**) and theonellasterone (**5**).
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^1^H and ^13^C NMR data for **1--3**.

           1                     2               3                                                           
  -------- --------------------- --------------- --------------------- --------------- --------------------- ---------------
  1        1.39 m; 1.82 m        37.2 (CH~2~)    1.38 m; 1.80 m        36.5 (CH~2~)    1.38 m; 1.79 m        36.5 (CH~2~)
  2        1.42 m; 1.98 m        32.7 (CH~2~)    1.50 m; 1.94 m        29.6 (CH~2~)    1.52 m; 1.94 m        29.6 (CH~2~)
  3        4.01 dd (11.0, 5.0)   73.2 (CH)       5.15 dd (12.0, 5.0)   74.8 (CH)       5.15 dd (12.0, 5.0)   74.8 (CH)
  4                              151.9 (C)                             148.0 (C)                             148.0 (C)
  5        1.97 m                45.1 (CH)       1.89 d (13.0)         49.5 (CH)       1.90 m                49.5 (CH)
  6        2.07 m; 2.14 m        25.1 (CH~2~)    1.38 m; 1.84 m        27.0 (CH~2~)    1.40 m; 1.84 m        27.0 (CH~2~)
  7        5.68 d (5.5)          125.0 (CH)      2.25 m                25.8 (CH~2~)    2.25 m                25.8 (CH~2~)
  8                              135.5 (C)                             125.5 (C)                             125.6 (C)
  9        2.17 m                45.4 (CH)       1.80 m                49.1 (CH)       1.80 m                49.1 (CH)
  10                             37.2 (C)                              39.8 (C)                              39.8 (C)
  11       1.47 m; 1.64 m        20.8 (CH~2~)    1.48 m; 1.64 m        20.4 (CH~2~)    1.48 m; 1.64 m        20.4 (CH~2~)
  12       1.62 m; 1.82 m        30.5 (CH~2~)    1.14 m; 1.96 m        37.3 (CH~2~)    1.15 m; 1.96 m        37.3 (CH~2~)
  13                             47.3 (C)                              42.7 (C)                              42.8 (C)
  14                             98.3 (C)                              143.1 (C)                             143.0 (C)
  15       1.34 m;               26.9 (CH~2~)    1.75 m;               29.2 (CH~2~)    1.77 m;               29.2 (CH~2~)
           2.06 m                                2.47 dd (13.5, 1.0)                   2.47 d (14.0)         
  16       1.62 m; 2.08 m        24.8 (CH~2~)    1.36 m; 1.60 m        24.5 (CH~2~)    1.36 m; 1.59 m        24.5 (CH~2~)
  17       1.85 m                50.9 (CH)       1.16 m                56.7 (CH)       1.17 m                56.7 (CH)
  18       0.74 s                17.0 (CH~3~)    0.84 s                18.2 (CH~3~)    0.85 s                18.2 (CH~3~)
  19       0.71 s                13.6 (CH~3~)    0.62 s                13.1 (CH~3~)    0.62 s                13.1 (CH~3~)
  20       1.37 m                36.3 (CH)       1.46 m                34.9 (CH)       1.50 m                34.4 (CH)
  21       0.89 d (7.0)          19.0 (CH~3~)    0.95 d (6.5)          19.2 (CH~3~)    0.96 d (6.5)          19.1 (CH~3~)
  22       1.00 m; 1.40 m        34.0 (CH~2~)    1.06 m; 1.41 m        33.7 (CH~2~)    1.24 m; 1.60 m        34.4 (CH~2~)
  23       1.04 m; 1.34 m        26.7 (CH~2~)    1.04 m; 1.32 m        26.2 (CH~2~)    1.90 m; 2.08 m        30.8 (CH~2~)
  24       0.94 m                46.0 (CH)       0.92 m                46.1 (CH)                             156.9 (C)
  25       1.68 m                29.0 (CH)       1.68 m                28.9 (CH)       2.24 m                33.8 (CH)
  26       0.81 d (7.0)          18.9 (CH~3~)    0.82 d (8.5)          19.0 (CH~3~)    1.03 d (7.0)          21.9 (CH~3~)
  27       0.83 d (7.0)          19.6 (CH~3~)    0.83 d (7.0)          19.5 (CH~3~)    1.04 d (7.5)          22.0 (CH~3~)
  28       1.14 m; 1.32 m        23.0 (CH~2~)    1.16 m; 1.32 m        23.0 (CH~2~)    4.67 s; 4.73 s        105.9 (CH~2~)
  29       0.86 t (7.5)          12.3 (CH~3~)    0.86 t (7.5)          12.3 (CH~3~)    4.60 s; 4.89 s        103.7 (CH~2~)
  30       4.74 s; 5.18 s        103.6 (CH~2~)   4.60 s; 4.89 s        103.7 (CH~2~)                         
  3-OAc                                          2.13 s                21.2 (CH~3~)    2.13 s                21.2 (CH~3~)
                                                                       170.2 (C)                             170.2 (C)
  14-OOH   6.79 br s                                                                                         

^a^ 500 MHz in CDCl~3~; ^b^ 125 MHz in CDCl~3~; ^c^ *J* values (Hz) are given in parentheses; ^d^ Numbers of attached protons were deduced by DEPT experiments.

Theonellasterol K (**1**) was obtained as a white amorphous solid. The HRESIMS spectrum of **1** exhibited a pseudomolecular ion peak at *m*/*z* 481.3659 \[M + Na\]^+^, which established a molecular formula of C~30~H~50~O~3~, implying six degrees of unsaturation. IR absorptions were observed at 3362 and 3251 cm^−1^, suggesting the presence of hydroxy groups in **1**. The structure of this compound was deduced from its ^13^C NMR and DEPT spectroscopic data ([Table 1](#marinedrugs-10-01536-t001){ref-type="table"}), which showed that the compound has 30 carbons, including six methyls, ten sp^3^ methylenes, one sp^2^ methylene, seven sp^3^ methines (including one oxymethine), one sp^2^ methine, three sp^3^ quaternary carbons and two sp^2^ quaternary carbons. From the ^1^H NMR spectrum of **1**, resonances of one olefinic methine proton (δ 5.68, d, *J* = 5.5 Hz), two olefinic methylene protons (δ 5.18 and 4.74, each s) and one oxygenated methine (δ 4.01, dd, *J* = 11.0, 5.0 Hz) were observed. Moreover, the ^1^H NMR spectrum revealed the presence of one hydroperoxy proton resonating as a broad singlet at δ~H~ 6.79. The planar structure and all of the ^1^H and ^13^C chemical shifts of **1** were elucidated by 2D NMR spectroscopic analysis, in particular ^1^H-^1^H COSY and HMBC experiments ([Figure 2](#marinedrugs-10-01536-f002){ref-type="fig"}). From the ^1^H-^1^H COSY correlations, it was found that one ring-juncture methine proton H-5 (δ 1.97) and one oxymethine proton H-3 (δ 4.01) exhibited allylic correlations with the exomethylene protons at C-30 (δ~H~ 4.74 and 5.18). In addition, ^1^H-^1^H COSY spectral analysis established five partial structures of consecutive proton spin systems ([Figure 2](#marinedrugs-10-01536-f002){ref-type="fig"}). Further analysis of the HMBC correlations was employed successfully to establish the gross structure of **1** ([Figure 2](#marinedrugs-10-01536-f002){ref-type="fig"}). Thus, **1** was found to possess two double bonds at C-7/C-8 and C-4/C-30, one hydroxy group at C-3 and one hydroperoxy group at C-14.

![Selected ^1^H-^1^H COSY (▬) and HMBC (→) correlations of **1**.](marinedrugs-10-01536-g002){#marinedrugs-10-01536-f002}

The relative configuration of **1**, elucidated mainly from the NOESY spectrum, was compatible with that of **1** ascertained using molecular mechanics calculations (MM2), which suggested the most stable conformations, as shown in [Figure 3](#marinedrugs-10-01536-f003){ref-type="fig"}. In the NOESY spectrum of **1**, the NOE correlations between one of the methylene protons at C-11 (δ~H~ 1.47) and both methyls (H~3~-18 and H~3~-19); H~3~-18 and H-20 as well as between H~3~-18, H~3~-19 and H-20 indicated that these protons adapt a *β*-orientation. H-5 was found to interact with H-3, but not with H~3~-19, revealing the *β* orientation of the hydroxy group at C-3. Moreover, the *α*-orientation of 14-OOH was further confirmed by the lower field chemical shift of H-17 (δ~H~ 1.85, m). Furthermore, the chemical shifts of the side chain from C-20 to C-29 in **1** were nearly identical to those of **4** and **5**. Thus, the structure of steroid **1** was established. After determining the structure of **1**, we discovered that its molecular framework has been obtained as a known 4-methylenesterol conicasterol H, which was isolated previously from sponge *Theonella swinhoei* \[[@B18-marinedrugs-10-01536]\].

![Computer-generated model of **1** using MM2 force field calculations and selected NOE correlations from C-1--C-21 of **1**.](marinedrugs-10-01536-g003){#marinedrugs-10-01536-f003}

Acetyltheonellasterol (**2**) was isolated as a white powder with the molecular formula C~32~H~52~O~2~, which possesses seven degrees of unsaturation, as indicated by HRESIMS (*m*/*z* 491.3862, \[M + Na\]^+^) and NMR spectroscopic data ([Table 1](#marinedrugs-10-01536-t001){ref-type="table"}). By comparison of the NMR data of **2** with those of **4**, it was found that the ^1^H and ^13^C NMR data of **2** were very similar to those of **4**, with the difference that **2** contains one more acetyl group relative to **4**. The chemical shift of H-3 in **4** (δ~H~ 4.01) was shifted downfield (δ~H~ 5.15) in **2**, suggesting that **2** is the 3-acetyl derivative of **4**. We observed further that acetylation of **4** gave a product which was found to be identical to **2** by comparison of the physical and spectroscopic data. Thus, compound **2** was established as the 3-acetyl derivative of **4**.

The new metabolite acetyldehydroconicasterol (**3**) was obtained as a white powder and possessed the molecular formula C~31~H~48~O~2~, as established from the HRESIMS and NMR data, implying eight degrees of unsaturation. Both the ^1^H and ^13^C NMR signals of **3** were found to be very closely related to those of compound **2**, suggesting a very similar steroidal skeleton. By comparison of the NMR data of **3** with those of **2** ([Table 1](#marinedrugs-10-01536-t001){ref-type="table"}), it was found that an ethyl protons signal \[δ~H~ 0.86 t, *J* = 7.5 Hz (H~3~-29); 1.16 m and 1.32 m (H~2~-28)\] in **2** was replaced by two exomethylene proton signals (δ~H~ 4.73 and 4.67, each s) in **3**. The only difference observed was that the 24-ethyl side chain of **2** was replaced by two exomethylene proton signals in **3**. This was further confirmed by the HMBC correlations from H~2~-28 to C-23, C-24, and C-25. On the basis of the above analysis, the structure of **3** was established.

Finally, we used a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay to examine the cytotoxic activities of compounds **1--5** against DLD-1, T47D, HCT-116, MCF-7, MDA-MB-231, K562 and Molt 4 cancer cells. Cells were treated with different concentrations of **1--5** for 72 h. The results showed that compound **1**, the most potent of compounds **1--5**, exhibited cytotoxicity against DLD-1, T47D, HCT-116, MDA-MB-231, K562 and Molt 4, with IC~50~s of 12.9, 12.0, 6.3, 11.5, 11.4, 4.3, and 6.3 μg/mL, respectively. Furthermore, compound **2** exhibited weak cytotoxic activity against K562 and Molt 4 cancer cell lines (the IC~50~ values were 13.7 and 17.8 μg/mL for K562 and Molt 4, respectively). The other tested compounds were not cytotoxic (IC~50~ \> 20 μg/mL) towards the above seven cancer cell lines ([Table 2](#marinedrugs-10-01536-t002){ref-type="table"}).
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Cytotoxicity (IC~50~ μg/mL) of compounds **1--5** ^a^.

                        Cell Lines                                              
  --------------------- ------------ -------- -------- -------- -------- ------ -------
  **1**                 12.9         12.0     6.3      11.5     11.4     4.3    6.3
  **2**                 -- ^c^       -- ^c^   -- ^c^   -- ^c^   -- ^c^   13.7   17.8
  **Doxorubicin ^b^**   0.42         0.28     0.89     2.2      1.3      0.14   0.009

^a^ Compounds **3--5** was inactive against all seven cell lines (IC~50~ \> 20 μg/mL); *^b^* Clinical anticancer drug used as a positive control; ^c^ NA, not active at 20 μg/mL.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotation values were measured with a Jasco P-1010 digital polarimeter. IR spectra were recorded on a Varian Digilab FTS 1000 Fourier transform infrared spectrophotometer. The NMR spectra were recorded on a Varian Mercury Plus 400 FT-NMR (or Varian Unity INOVA 500 FT-NMR) instrument at 400 MHz (or 500 MHz) for ^1^H-NMR and 100 MHz (or 125 MHz) for ^13^C-NMR, respectively, in CDCl~3~. ESIMS were obtained with a Bruker APEX II mass spectrometer. Gravity column chromatography was performed on silica gel (230--400 mesh, Merck). TLC was carried out on precoated Kieselgel 60 F254 (0.2 mm, Merck) and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. High-performance liquid chromatography (HPLC) was performed using a system comprised of a Hitachi L-7100 pump and a Rheodyne 7725 injection port. A preparative normal phase column (250 × 21.2 mm, 5 μm) was used for HPLC.

3.2. Animal Material
--------------------

The specimen of *Theonella swinhoei* was collected by scuba divers at a depth of 15--20 m from coral reefs off the coast of Pingtung, Taiwan. A voucher specimen was deposited in the National Museum of Marine Biology and Aquarium, Taiwan (specimen no. 2011SP-2). Taxonomic identification was performed by Prof. Wen-Been Chang of the National Museum of Marine Biology & Aquarium, Pingtung, Taiwan.

3.3. Extraction and Separation
------------------------------

The sponge *Theonella swinhoei* (2.2 kg fresh wt) stored frozen and then freeze dried. The freeze-dried material (590 g) was minced and extracted exhaustively with EtOAc (5 × 2 L). The EtOAc extract was evaporated to yield a residue (11.9 g), which was subjected to open column chromatography on silica gel eluting with *n*-hexane (H)-EtOAc (E) gradient and EtOAc (E)-acetone (A) gradient, to give 12 fractions: Fr-1 (eluted by H-E 100:1), Fr-2 (eluted by H-E 50:1), Fr-3 (eluted by H-E 30:1), Fr-4 (eluted by H-E 20:1), Fr-5 (eluted by H-E 10:1), Fr-6 (eluted by H-E 8:1), Fr-7 (eluted by H-E 5:1), Fr-8 (eluted by H-E 3:1), Fr-9 (eluted by H-E 1:1), Fr-10 (eluted by EtOAc), Fr-11 (eluted by E-A 1:1) and Fr-12 (eluted by acetone). Fraction 2 (250 mg), was subjected to normal phase HPLC (Hibar 250 × 21.2 mm, Supelco, silica gel 60, 5 μm), using *n*-hexane--EtOAc (25:1) as eluent, to afford four subfractions (A1--A4). Subfraction A1 (50 mg) was separated by normal phase HPLC using *n*-hexane--EtOAc (25:1) to afford **2** (25.5 mg, 0.21% dry wt of extract) and **3** (1.8 mg, 0.015% dry wt of extract). Subfraction A3 (120 mg) was also purified by normal phase HPLC using *n*-hexane--EtOAc (15:1) to afford **5** (55 mg, 0.46% dry wt of extract). Fraction 5 (2.5 g), was further separated by silica gel open column chromatography with gradient elution (*n*-hexane--EtOAc, 10:1 to 5:1) to afford **4** (1.2 g, 10.1% dry wt of extract). Fraction 7 (250 mg), was further separated by normal phase HPLC (*n*-hexane--EtOAc, 5:1) to yield six subfractions (B1--B6). Subfraction B3 (30 mg) was separated by normal phase HPLC using *n*-hexane--acetone (6:1) to afford **1** (12.5 mg, 0.11% dry wt of extract).

Theonellasterol K (**1**): white powder; \[α\]^24^~D~ = +82 (*c* 0.2, CHCl~3~); IR (neat) ν~max~ 3362, 3251, 2956, 2870, 1644, 1451 and 1376 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01536-t001){ref-type="table"}; ESIMS *m*/*z* 481 \[50, (M + Na)^+^\]; HRESIMS *m*/*z* 481.3659 (calcd. for C~30~H~50~O~3~Na, 481.3657).

Acetyltheonellasterol (**2**): white powder; \[α\]^24^~D~ = −3 (*c* 1.0, CHCl~3~); IR (neat) ν~max~ 2957, 1744, 1644, and 1373 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01536-t001){ref-type="table"}; ESIMS *m*/*z* 491 \[80, (M + Na)^+^\]; HRESIMS *m*/*z* 491.3862 (calcd. for C~32~H~52~O~2~Na, 491.3865).

Acetyldehydroconicasterol (**3**): white powder; \[α\]^24^~D~ = −5 (*c* 0.1, CHCl~3~); IR (neat) ν~max~ 2927, 1742, and 1376 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-10-01536-t001){ref-type="table"}; ESIMS *m*/*z* 475 \[100, (M + Na)^+^\]; HRESIMS *m*/*z* 475.3555 (calcd. for C~31~H~48~O~2~Na, 475.3552).

Acetylation of **4**: A solution of **4** (10.0 mg) in pyridine (0.2 mL) was mixed with Ac~2~O (0.2 mL), and the mixture was stirred at rt for 24 h. After evaporation of excess reagent, the residue was subjected to column chromatography over Si gel using *n*-hexane--EtOAc (7:1) to yield **2** (10.5 mg, 95%). The specific rotation \[\[α\]^24^~D~ = −3 (*c* 0.5, CHCl~3~)\] was in full agreement with that of the natural product **2**.

3.4. Cytotoxicity Testing
-------------------------

Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays of compounds **1--5** were performed using the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] colorimetric method \[[@B22-marinedrugs-10-01536],[@B23-marinedrugs-10-01536]\].

3.5. Molecular Mechanics Calculations
-------------------------------------

Implementation of the MM2 force filed in Chem3D Pro software \[[@B24-marinedrugs-10-01536]\] was used to calculate the molecular models.

4. Conclusions
==============

A series of new 4-methylenesterols were isolated from the sponge *Theonella swinhoei* \[[@B8-marinedrugs-10-01536],[@B9-marinedrugs-10-01536],[@B10-marinedrugs-10-01536],[@B11-marinedrugs-10-01536],[@B12-marinedrugs-10-01536],[@B13-marinedrugs-10-01536],[@B14-marinedrugs-10-01536],[@B15-marinedrugs-10-01536],[@B16-marinedrugs-10-01536],[@B17-marinedrugs-10-01536],[@B18-marinedrugs-10-01536],[@B19-marinedrugs-10-01536],[@B20-marinedrugs-10-01536],[@B21-marinedrugs-10-01536]\]. Our continued investigation of the chemical constituents of sponge *T. swinhoei* has again led to the isolation of three new 4-methylenesterols (**1--3**) and two known 4-methylenesterols (**4** and **5**). Compound **1** exhibited significant cytotoxicity against HCT-116, K562 and Molt 4 cells, and moderate to weak cytotoxicity against DLD-1, MCF-7, and MDA-MB-231 cells. In addition, compound **2** exhibited weak cytotoxicity toward K562 and Molt 4 cell lines. However, the new compound **3** and the other known compounds had no significant activity. According to our research, metabolite **1** exhibited significant cancer cells inhibitory activity. This result suggests that **1** should be subjected to further biomedical investigation.
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